Skip to content
10-Q

Quarterly Report

APELLIS PHARMACEUTICALS, INC.

0000950170-25-100545

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 24, 2025 126.29M sh
Shares Diluted Q2 2025 · Jun 30, 2025 126.02M sh
Shares Diluted Q2 2025 · Jun 30, 2025 125.74M sh
Shares Diluted Q2 2025 · Jun 30, 2024 123.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 123.43M sh
Capex Q2 2025 · Jun 30, 2025 $57K
Capex Q2 2025 · Jun 30, 2024 $383K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$48.97M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$141.32M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $370.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $411.29M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $360.09M
Stockholders Equity Q2 2025 · Jun 30, 2025 $156.31M
Stockholders Equity Q2 2025 · Mar 31, 2025 $164.22M
Stockholders Equity Q2 2025 · Dec 31, 2024 $228.54M
Stockholders Equity Q2 2025 · Jun 30, 2024 $264.33M
Stockholders Equity Q2 2025 · Mar 31, 2024 $266.68M
Stockholders Equity Q2 2025 · Dec 31, 2023 $194.52M
Current Liabilities Q2 2025 · Jun 30, 2025 $200.66M
Current Liabilities Q2 2025 · Dec 31, 2024 $185.51M
Total Liabilities Q2 2025 · Jun 30, 2025 $665.09M
Total Liabilities Q2 2025 · Dec 31, 2024 $656.51M
Current Assets Q2 2025 · Jun 30, 2025 $755.61M
Current Assets Q2 2025 · Dec 31, 2024 $788.95M
Total Assets Q2 2025 · Jun 30, 2025 $821.39M
Total Assets Q2 2025 · Dec 31, 2024 $885.05M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.33
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.07
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.84
Eps Basic Q2 2025 · Jun 30, 2025 −$0.33
Eps Basic Q2 2025 · Jun 30, 2025 −$1.07
Eps Basic Q2 2025 · Jun 30, 2024 −$0.30
Eps Basic Q2 2025 · Jun 30, 2024 −$0.84
Sga Expense Q2 2025 · Jun 30, 2025 $131.14M
Sga Expense Q2 2025 · Jun 30, 2025 $260.48M
Sga Expense Q2 2025 · Jun 30, 2024 $128.08M
Sga Expense Q2 2025 · Jun 30, 2024 $257.59M
Rd Expense Q2 2025 · Jun 30, 2025 $67.02M
Rd Expense Q2 2025 · Jun 30, 2025 $153.44M
Rd Expense Q2 2025 · Jun 30, 2024 $77.95M
Rd Expense Q2 2025 · Jun 30, 2024 $162.65M
Net Income Q2 2025 · Jun 30, 2025 −$42.15M
Net Income Q2 2025 · Jun 30, 2025 −$134.38M
Net Income Q2 2025 · Mar 31, 2025 −$92.23M
Net Income Q2 2025 · Jun 30, 2024 −$37.66M
Net Income Q2 2025 · Jun 30, 2024 −$104.08M
Net Income Q2 2025 · Mar 31, 2024 −$66.42M
Operating Income Q2 2025 · Jun 30, 2025 −$33.29M
Operating Income Q2 2025 · Jun 30, 2025 −$116.61M
Operating Income Q2 2025 · Jun 30, 2024 −$29.44M
Operating Income Q2 2025 · Jun 30, 2024 −$91.53M
Revenue Q2 2025 · Jun 30, 2025 $178.49M
Revenue Q2 2025 · Jun 30, 2025 $345.29M
Revenue Q2 2025 · Jun 30, 2024 $199.69M
Revenue Q2 2025 · Jun 30, 2024 $372.01M